Opioid Use Disorder
Conditions
Keywords
Opioid Use Disorder, Drug Disposal, at-home drug disposal, Drug Diversion, Opioid Disposal
Brief summary
There is an urgent unmet medical need for a cost-effective, environmentally friendly, in-home opioid disposal solution for surgical patients that is clinically proven to reduce opioid use disorder that is substantiated with economic data. SafeMedWaste, Inc. (SMW) has developed the patented SafeMedWaste in-home drug disposal container, that completely destroys opioids within minutes and can be placed in the regular trash, without risk of ground or municipal water contamination. A pilot randomized clinical trial will evaluate the use of SafeMedWaste in 300 adult patients in outpatient surgery clinics undergoing shoulder and knee surgery.
Detailed description
The trial will evaluate opioid disposal rates and events related to opioid diversion and use disorder in 300 adult patients 18 years of age and older undergoing outpatient knee and shoulder surgery who are prescribed opioids to manage their acute post-surgical pain. Patients will be randomized into two arms. During the standard of care post op visits (2-, 6- and 10- weeks), when the treating physician has determined that the patient will no longer need opioids to manage their post-surgical pain, all patients will receive general instructions by video on opioid disposal recorded by one of the orthopedic surgeons. Patients in the treatment arm will also be given the SafeMedWaste opioid disposal system and watch an instructional video on how to use the product. All patients will complete a pre-surgery survey and a post-surgery survey 90 days after surgery. Patients will self-report their disposal or non-disposal of the drugs, documented with pictures uploaded to the patient's MyChart account. Data from the surveys will be statistically analyzed to identify significant factors that influenced patients' behavior vis-à-vis opioid disposal.
Interventions
DEVICESafeMedWaste
SafeMedWaste opioid disposal kit
Sponsors
Prisma Health-Midlands
University of South Carolina
National Institute on Drug Abuse (NIDA)
SafeMedWaste, Inc.
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Inclusion Criteria: * Subject is 18 + years of age * Subject is opioid naive (within the last 3 months), as evidenced by MyChart patient record or response to medical history questions * Subject is scheduled to undergo shoulder and/or knee surgery
Exclusion criteria
* Subject has a history of opioid addiction, as evidenced by MyChart patient record or response to medical history questions * Subject is currently utilizing prescription narcotics for any reason, as evidenced by MyChart patient record or response to medical history questions * Subject does not have the mental capacity to make their own healthcare decisions * Subject is unable to provide written consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Opioid disposal compliance | Within 3 months following surgery | Opioid disposal compliance will be tracked up to 3 months post-surgery, as reported by patients in post-surgery survey and/or documented with pictures uploaded by patient to MyChart. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Time of disposal | Within 3 months following surgery | When the patients dispose of opioids, as reported by patients in post-surgery survey and/or documented with pictures in MyChart, will be tracked up to 3 months post-surgery. |
| Amount of opioids used | Within 3 months following surgery | The amount of opioids used will be tracked at visit weeks 2, 6 and 10, post surgery, through clinic pill counts, or as self-reported by patients up to 3 months. |
| Opioid Use Disorder (OUD) | Within 3 months following surgery | Any OUD reported in the patient medical record will be tracked up to 3 months following surgery. |
| Reasons for disposal/non- disposal | Within 3 months following surgery | Reasons why the patient chose to dispose of opioids or chose not to, as reported in the post- surgery survey, will be statistically analyzed and correlated as appropriate to other data. |
| Pre-Surgery Survey | At enrollment | Pre-Surgery Survey, see Ex. 1, Protection of Human Subjects, will be completed by patients at enrollment. Questions include patient past surgical experience and attitudes toward pain. Data will be recorded in REDCap and statistically analyzed. |
| Post-Surgery Survey | 3 months following surgery | Patients will answer post-surgery survey, see Ex. 2, Protection of Human Subjects, within 3 months following surgery. Questions include pain experiences from their surgery and disposal compliance. Data will be recorded in REDCAP and statistically analyzed for correlations of patient attitudes toward and experience with pain and other factors to disposal compliance to create clinician/patient education protocols to be studied in future trial. |
| Provider Satisfaction Survey | Upon study completion | Provider participants will answer Provider Satisfaction survey, see Ex. 4, Protection of Human Subjects, upon study completion. Data will be recorded in REDCap and statistically analyzed. |
| Diversion event | Within 3 months following surgery | Any diversion event as described by patient at clinical visit or in post-surgery survey will be recorded. |
Contacts
Primary ContactJustin Stas, B.S Biomedical Engineering
Backup ContactPaisley T Myers, PhD Bioanalytical chemistry
Outcome results
None listed